fluorescence imaging technologies

ICG fluorescence shows higher SLN detection and sensitivity than gamma tracing in head and neck cancer. Promising tool for staging accuracy.

ICG fluorescence imaging safely verifies uterine perfusion during robotic transposition, helping prevent ischemia or necrosis post-op.

Segmental bronchial marking with ICG improves safety and accuracy in thoracoscopic segmentectomy, especially for complex lung resections.

The acquisition is set to create a comprehensive surgical intelligence platform that offers objective and standardised perfusion assessments. This innovation is expected to reduce surgical risks and improve clinical outcomes across various procedures, including colorectal, reconstructive, and vascular surgeries. Additionally, the integration opens new commercial opportunities in chronic wound care and diabetic foot ulcer treatment, potentially benefiting over 18 million patients globally.

ICG offers a safe, cost-effective alternative to 99mTc for sentinel lymph node mapping in early breast cancer, with a 98% detection rate.

ICG-guided imaging in neonatal surgery proves safe and effective, aiding anatomy visualization and decision-making in diverse procedures.

ICG fluorescence angiography reduces anastomotic leaks in both high and low anterior resections, supporting its use in colorectal surgery.

ICG ureteral instillation enables safer hysterectomies for gynecologic cancer, aiding visualization in post-surgical pelvic anatomy.

Robotic-assisted hysterectomy offers precision, reduced morbidity, and faster recovery in endometrial cancer, benefiting high-risk patients.

The congress theme is: Modern HPB Surgery: When Innovation Becomes Standard. They aim to highlight the rapid advancements in our field and the transition of cutting-edge innovations into everyday clinical practice. The programme will showcase the latest breakthroughs and explore how these innovations are shaping the future of HPB surgery.